Home › Epilepsy › NCT06617845
Optimizing Brain Stimulation Parameters
Recruiting
Who can join
Ages 6 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients who are implanted with a brain stimulation device targeting the anterior nucleus of the thalamus per Mayo Clinic standard of care Exclusion Criteria: * Patients for whom clinical follow-up is not expected during the initial 6-8 months following implant
About the study
A primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study will help assess the effectiveness of low frequency or high frequency stimulation.
What is being tested
- Stimulation Set A and B (device)
Sponsor: Mayo Clinic · Participants: 30 · Started: Oct 20, 2020
Contact the study team
- Amy Headlee · Phone: 507-538-4107
- Karla Crockett · Phone: 507-538-4880
Official record on ClinicalTrials.gov — NCT06617845
Locations in the U.S.
| Minnesota | Mayo Clinic Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.